Safety of Gadobutrol: Results of a Non-Interventional Study of 3710 Patients, Including 404 Children

Acta Radiologica - United Kingdom
doi 10.1177/0284185118801151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Ct-P10 Rapid Infusion in Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukaemia: Interim Results From a Non-Interventional Post-Authorisation Safety Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Renal Tolerance of a Neutral Gadolinium Chelate (Gadobutrol) in Patients With Chronic Renal Failure: Results of a Randomized Study

Radiology
Nuclear MedicineRadiologyImaging
2001English

Sandoz Rituximab for Treatment of Diffuse Large B-Cell Lymphoma: Interim Safety Results of the Non-Interventional, Observational, Multicenter, Open-Label Reflect Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Non-Interventional Study of Efficacy and Safety of Rosuvastatin Therapy and Introduction of Additional Doses to Clinical Practice in Patients With Hyperlipidemia

Cardiologia Croatica
Cardiovascular MedicineCardiology
2020English

Safety and Efficacy of Gadobutrol for Contrast-Enhanced Magnetic Resonance Imaging of the Central Nervous System: Results From a Multicenter, Double-Blind, Randomized, Comparator Study

Magnetic Resonance Insights
2015English

Results From the Implementation of a Surgical Safety Checklist (SSC) at an Interventional Radiology Unit

Safety in Health
2015English

Initial Results of a Safety and Feasibility Study of Auditory Brainstem Implantation in Congenitally Deaf Children

Otology and Neurotology
MedicineOtorhinolaryngologySensory SystemsNeurology
2017English

One-Year Safety and Quality of Life Outcomes in Patients With Atrial Fibrillation on Dronedarone: Prospective, Non-Interventional Study in German Ambulatory Care

Herzschrittmachertherapie und Elektrophysiologie
MedicineCardiovascular MedicinePhysiologyCardiology
2015English

Tolerability and Safety of the Intravenous Immunoglobulin Octagam® 10% in Patients With Immune Thrombocytopenia: A Post-Authorisation Safety Analysis of Two Non-Interventional Phase IV Trials

Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy